Physician profile
Peter Michael Lewis
NPI 1700869161
$423.64
in general payments reported to CMS, 2019-2025
9 companies · $41.84 in 2025
The $41.84 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.02 · 2021: $65.03 · 2022: $134 · 2023: $73.24 · 2024: $97.79 · 2025: $41.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $212.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $103.44 | 2022 | |
| Abiomed | $97.79 | 2024 | Impella |
| Livanova USA, INC. | $73.24 | 2023 | Lifesparc |
| Medtronic, INC. | $50.33 | 2021-2025 | Tyrx |
| Novartis Pharmaceuticals Corporation | $30.28 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $23.43 | 2025 | Opsynvi |
| Cardiovascular Systems INC. | $18.31 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.80 | 2021 | |
| Terumo Medical Corporation | $12.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.